Earnings

AbbVie Lowers FY2026 Adj EPS Guidance from $14.08-$14.28 to $13.87-$14.07 vs $14.08 Est

Jul 31, 2026 · 07:52 AM ET· updated 3h ago

AbbVie (NYSE:ABBV) lowers FY2026 Adj EPS guidance from $14.08-$14.28 to $13.87-$14.07 vs $14.08 analyst estimate..

Why It Matters

AbbVie said it will probably earn a little bit less money next year than it thought before—like revising a test score down slightly. When a big company lowers its profit forecast, it's a sign they're being careful and honest, so watch whether they explain why and if other similar companies do the same.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ABBV254.14

-3.27 (-1.27%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.